Compliance with Uresta (CURE) study; a 12 month follow-up of 40 women.

Campbell P1, Moran K2, Gallagher C1, Boyle S1

Research Type

Clinical

Abstract Category

Continence Care Products / Devices / Technologies

Abstract 7
Products, Devices and Innovative Therapies
Scientific Podium Short Oral Session 2
Thursday 8th September 2022
09:05 - 09:12
Hall K1/2
Conservative Treatment Prospective Study Quality of Life (QoL) Questionnaire Stress Urinary Incontinence
1. Kingsbridge Private Hospital, 2. NIMDTA
In-Person
Presenter
Links

Abstract

Hypothesis / aims of study
Stress urinary incontinence (SUI) has been shown to affect almost half of women who attend gyms or exercise classes [1,2].  Women who continue to exercise or take part in sporting activities may describe discomfort, reduced levels of enjoyment, embarrassment and loss of confidence. Vaginal devices are an appropriate management option for this cohort of women, especially those who wish to avoid surgery for incontinence [3].  Research on incontinence devices is limited and has typically focussed on clinical parameters such as pad tests, rather than long-term compliance and patient reported outcomes.The Uresta bladder support is an effective management option for women with stress urinary incontinence (SUI), however, there is a lack of data assessing long-term compliance. The aim of this study was to assess compliance at 12 month follow-up in women using the Uresta bladder support for exercise related SUI.
Study design, materials and methods
This was a prospective study of the Uresta bladder support in women who reported SUI during exercise in the United Kingdom. The study was advertised on social media, running clubs and gyms.  Participants were fitted with a Uresta bladder support and followed up over a 12 month period.   Power calculation recommended a sample size of 43.  Ethical approval was obtained.  Outcomes were assessed using the PUQ, ICIQ-FLUTS, UDI-6, IIQ-7, QUID and PGI-I questionnaires.
Results
Forty-six women were recruited with an average age, BMI and parity of 42, 24 and 2.3 respectively.  The most common activities were running (48%) and CrossFit (22%).  Six participants withdrew after 2 weeks.  Compliance was 90% at 12 months (n=40).  Uresta insertion was 'okay', 'easy' or 'very easy' for 86% of participants and removal was 'okay', 'easy' or 'very easy' for 75% of participants, Leakage was improved (n=13), greatly improved (n=12) or stopped (n=5) for 83% of participants, 75% were ‘much better’ or ‘very much better’ on the PGI-I scale, and 94% would recommend Uresta to a friend.  There were no adverse events.
Interpretation of results
The Uresta bladder support is a safe, effective, user-friendly management option for women who experience SUI during exercise with excellent long-term compliance.  Future studies should identify predictors of successful fitting with incontinence devices and compare the efficacy, ease of use, compliance and cost-effectiveness between different devices currently available.  Furthermore, development of a specific, validated questionnaire assessing impact of SUI with exercise and impact of incontinence devices would be a valuable resource for future research in this area.
Concluding message
The Uresta bladder support is a safe, effective, user-friendly management option for women with exercise related SUI with 90% compliance at 12-month follow up.
Figure 1 Study flow chart
Figure 2 Uresta bladder support
References
  1. McKenzie S, Watson T, Thompson J, Briffa (2016) Stress urinary incontinence is highly prevalent in recreationally active women attending gyms or exercise classes. Int Urogynecol J;27(8):1175-84.
  2. Yang J, Cheng JW, Wagner H, Lohman E, Yang SH, Krishingner GA et al (2019) The effect of high impact crossfit exercises on stress urinary incontinence in physically active women. Neurourol Urodyn;38(2):749–56
  3. Urinary incontinence and pelvic organ prolapse in women: management. NICE guideline [NG123] Published 02 April 2019.
Disclosures
Funding The study design was not influenced by the supplier or inventor of Uresta and the research team did not receive any financial reward for conducting the study. The study was conducted in a private clinic. Funding for room hire and nurse chaperone, as well as a supply of Uresta bladder supports, was provided by the UK supplier of Uresta. Clinical Trial No Subjects Human Ethics Committee Northern Ireland Research Ethics Committee Helsinki Yes Informed Consent Yes
Citation

Continence 2S2 (2022) 100197
DOI: 10.1016/j.cont.2022.100197

02/04/2025 08:28:58